Journals / Kocaeli Tıp Dergisi / 2020 / Cilt: 9 - Sayı: 1

Role of p-Coumaric Acid in Alleviating of The Intestinal Ischemia/Reperfusion Injury

İntestinal İskemi/Reperfüzyon Hasarının Hafifletilmesinde p-Kumarik Asit’in Rolü

Pages
166–173
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, in the p-coumaric acid 100 mg/kggroup, TAC value and SOD activity more increased and OSI,TOS values more decreased compared with p-coumaric acid50 mg/kg group.DISCUSSION AND CONCLUSION: It can say that thedifferent doses of the p-coumaric acid demonstrated protectiveeffects against intestinal I/R (1hour: 2hour) injury inexperimental animals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:INTRODUCTION: This study was planned to investigate theprotective role of p-coumaric acid against intestinalischemia/reperfusion (I/R) injury.METHODS: For this purpose, an experimental intestinal I/Rmodel was established in our study.
📊
Key Findings & Data:In the p-coumaric acid andI/R groups, superior mesenteric artery was clamped for 1 h.Then, the clamp was removed and reperfusion was allowed for2 h.
💡
Conclusion & Impact:Moreover, in the p-coumaric acid 100 mg/kggroup, TAC value and SOD activity more increased and OSI,TOS values more decreased compared with p-coumaric acid50 mg/kg group.DISCUSSION AND CONCLUSION: It can say that thedifferent doses of the p-coumaric acid demonstrated protectiveeffects against intestinal I/R (1hour: 2hour) injury inexperimental animals.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

INTRODUCTION: This study was planned to investigate theprotective role of p-coumaric acid against intestinalischemia/reperfusion (I/R) injury.METHODS: For this purpose, an experimental intestinal I/Rmodel was established in our study. In the p-coumaric acid andI/R groups, superior mesenteric artery was clamped for 1 h.Then, the clamp was removed and reperfusion was allowed for2 h. At the end of 2h, rats were sacrificed and intestinal tissuesamples were collected rapidly.RESULTS: It was determined that MPO activity, MDA levels,TOS and OSI values increased due to severe oxidative damagedepending on I/R. In addition, TAC value and SOD activitydecreased in the I/R group. Also, TAC value and SOD activityincreased while TOS, OSI values, MPO activity and MDA levelwere reducing in the I/R + p-coumaric acid (50 and 100 mg/kgbw.) groups. Moreover, in the p-coumaric acid 100 mg/kggroup, TAC value and SOD activity more increased and OSI,TOS values more decreased compared with p-coumaric acid50 mg/kg group.DISCUSSION AND CONCLUSION: It can say that thedifferent doses of the p-coumaric acid demonstrated protectiveeffects against intestinal I/R (1hour: 2hour) injury inexperimental animals.

Özet

GİRİŞ ve AMAÇ: Bu çalışma intestinal iskemi/reperfüzyon (İ/R) hasarına karşı p-kumarik asit’ in koruyucu rolünü araştırmak amacıyla planlandı. YÖNTEM ve GEREÇLER: Bu amaçla, çalışmamızda deneysel intestinal İ/R hasar modeli oluşturuldu. p-Kumarik asit ve İ/R gruplarında, süperior mezenterik arter 1 saat süreyle klemplendi. Bu sürenin sonunda klemp açıldı ve 2 saat süreyle reperfüzyona izin verildi.2 saatin sonunda, sıçanlar sakrifiye edildi ve intestinal doku örnekleri hızlıca toplandı. BULGULAR: İ/R’ye bağlı olarak şiddetli oksidatif hasardan dolayı MPO aktivitesi, MDA seviyesi, TOS and OSI değerlerinin arttığı belirlendi. İlaveten İ/R grubunda TAC değeri ve SOD aktivitesi azaldı. Ayrıca, İ/R + p-kumarik asit (50 ve 100 mg/kg) gruplarında MPO aktivitesi, MDA seviyesi, TOS and OSI değerleri azalırken TAC değeri ve SOD aktivitesi arttı. Dahası, p-kumarik asit 50 mg/kg grubu ile karşılaştırıldığı zaman p-kumarik asit 100 mg/kg grubunda TAC değeri ve SOD aktivitesi daha fazla artarken OSI ve TOS değerleri daha fazla azaldı. TARTIŞMA ve SONUÇ: p-Kumaraik asit’ in farklı dozları deney hayvanlarında intestinal İ/R (1saat: 2saat) hasara karşı koruyucu etki gösterdiği söylenilebilir.

🔖

Cite This Article

TANYELİ, A., GÜLÇİN, İ., ERASLAN, E., AKDEMİR, F. N. E., GÜLER, M. C., SEBİN, S. Ö. (2022). Role of p-Coumaric Acid in Alleviating of The Intestinal Ischemia/Reperfusion Injury. Kocaeli Tıp Dergisi, Cilt: 9 - Sayı: 1, 166–173. https://ajindex.com/articles/652962

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Campos VF, Miranda-Ferreira R, Taha NSA, Teixeira GD, Souza WTI, Carmo CEF, et al. Atenolol to Treat Intestinal Ischemia and Reperfusion in Rats. Transplantation Proceedings. 2012;44(8):2313-6
  2. Chang JX, Chen S, Ma LP, Jiang LY, Chen JW, Chang RM, et al. Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock. World Journal of Gastroenterology. 2005;11(35):5485-91
  3. Petrat F, Swoboda S, de Groot H, Schmitz KJ. Quantification of Ischemia-Reperfusion Injury to the Small Intestine Using a Macroscopic Score. Journal of Investigative Surgery. 2010;23(4):208-17
  4. Grootjans J, Lenaerts K, Buurman WA, Dejong CHC, Derikx JPM. Life and death at the mucosal-luminal interface: New perspectives on human intestinal ischemia-reperfusion. World Journal of Gastroenterology. 2016;22(9):2760-70
  5. Cerqueira NF, Hussni CA, Yoshida WB. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras. 2005;20(4):336-43
  6. Yasuhara H. Acute mesenteric ischemia: The challenge of gastroenterology. Surgery Today. 2005;35(3):185-95
  7. Zhao JP, Yu SJ, Tong LQ, Zhang F, Jiang X, Pan S, et al. Oxymatrine attenuates intestinal ischemia/reperfusion injury in rats. Surgery Today. 2008;38(10):931-7
  8. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190(3):255-66
  9. Oztürk Sarıkaya SB, Topal F, Şentürk M, Gülçin İ, Supuran CT. In vitro inhibition of αcarbonic anhydrase isozymes by some phenolic compounds. Bioorganic and Medicinal Chemistry Letters. 2011;21 (14):4259-62
  10. Sarikaya SBO, Gulcin I, Supuran CT. Carbonic Anhydrase Inhibitors: Inhibition of Human Erythrocyte Isozymes I and II with a Series of Phenolic Acids. Chem Biol Drug Des. 2010;75(5):515-20
  11. Ferguson LR, Lim IF, Pearson AE, Ralph J, Harris PJ. Bacterial antimutagenesis by hydroxycinnamic acids from plant cell walls. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2003;542(1-2):49-58
  12. Pragasam SJ, Venkatesan V, Rasool M. Immunomodulatory and Anti-inflammatory Effect of p-Coumaric Acid, a Common Dietary Polyphenol on Experimental Inflammation in Rats. Inflammation. 2013;36(1):169-76
  13. Sharma SH, Chellappan DR, Chinnaswamy P, Nagarajan S. Protective effect of p-coumaric acid against 1,2 dimethylhydrazine induced colonic preneoplastic lesions in experimental rats. Biomedicine & Pharmacotherapy. 2017;94:577-88
  14. Ekinci-Akdemir FN, Gulcin I, Gursul C, Alwasel SH, Bayir Y. Effec